Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Selects Bluebee as Data Processing Partner for MammaPrint, BluePrint IVD Kit

NEW YORK (GenomeWeb) – Agendia announced today that it has signed an agreement to have Dutch genomic data analysis firm Bluebee provide data processing services for a next-generation sequencing-based kit version of Agendia's molecular breast cancer diagnostics.

The kit allows Agendia's MammaPrint 70-gene breast cancer recurrence risk test and its BluePrint breast cancer subtyping assay to be performed by labs using existing NGS instruments, rather than sending them to the company for centralized processing. It is currently being validated with collaborators in anticipation of a European launch in early 2018.

According to Agendia, Bluebee will help provide secure global access to test kit results, while ensuring that all data complies with local data privacy and residency regulations. Additional terms of the deal were not disclosed.

"When choosing a data processing partner, it was important for us to work with a team that could deliver these results in a highly secure form," Marjolaine Baldo, Agendia's commercial vice president for Europe, the Middle East, and Africa, said in a statement. "We are very pleased to partner with Bluebee as we finalize the development of the MammaPrint BluePrint Kit ahead of European launch."

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.